相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。A phase I trial of arsenic trioxide chemoradiotherapy for infiltrating astrocytomas of childhood
Kenneth J. Cohen et al.
NEURO-ONCOLOGY (2013)
Phase I study of arsenic trioxide and temozolomide in combination with radiation therapy in patients with malignant gliomas
Sean A. Grimm et al.
JOURNAL OF NEURO-ONCOLOGY (2012)
Synergistic Anti-Tumor Effects of Combination of Photodynamic Therapy and Arsenic Compound in Cervical Cancer Cells: In Vivo and In Vitro Studies
Yong-Wan Kim et al.
PLOS ONE (2012)
Phase 1 trial and pharmacokinetic study of arsenic trioxide in children and adolescents with refractory or relapsed acute leukemia, including acute promyelocytic leukemia or lymphoma
Elizabeth Fox et al.
BLOOD (2008)
Involvement of mitochondrial aggregation in arsenic trioxide (As2O3)-induced apoptosis in human glioblastoma cells
N Haga et al.
CANCER SCIENCE (2005)
Arsenic trioxide (As2O3) inhibits invasion of HT1080 human fibrosarcoma cells:: Role of nuclear factor-κB and reactive oxygen species
MJ Park et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Diarsenic and tetraarsenic oxide inhibit cell cycle progression and bFGF- and VEGF-induced proliferation of human endothelial cells
SH Woo et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma
R Stupp et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Sulindac and its metabolites inhibit invasion of glioblastoma cells via down-regulation of Akt/PKB and MMP-2
HC Lee et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2005)
Arsenic trioxide prevents radiation-enhanced tumor invasiveness and inhibits matrix metalloproteinase-9 through downregulation of nuclear factor κB
LH Wei et al.
ONCOGENE (2005)
Increased cure rate of glioblastoma using concurrent therapy with radiotherapy and arsenic trioxide
SC Ning et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2004)
Arsenic trioxide enhances radiation response of 9L glioma in the rat brain
JH Kim et al.
RADIATION RESEARCH (2003)
Enhancement of radiation response in human cervical cancer cells in vitro and in vivo by arsenic trioxide (As2O3)
YJ Chun et al.
FEBS LETTERS (2002)
Suppression of matrix metalloproteinase-2 gene expression and invasion in human glioma cells by MMAC/PTEN
D Koul et al.
ONCOGENE (2001)
Association of increased phosphatidylinositol 3-kinase signaling with increased invasiveness and gelatinase activity in malignant gliomas
T Kubiatowski et al.
JOURNAL OF NEUROSURGERY (2001)
Akt/PKB promotes cancer cell invasion via increased motility and metalloproteinase production
D Kim et al.
FASEB JOURNAL (2001)
Inhibitory effect of selenite on invasion of HT1080 tumor cells
SO Yoon et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Clinical trials of arsenic trioxide in hematologic and slid tumors: Overview of the national cancer institute cooperative research and development studies
AJ Murgo
ONCOLOGIST (2001)
Matrix metalloproteinases in human gliomas: Activation of matrix metalloproteinase-2 (MMP-2) may be correlated with membrane-type-1 matrix metalloproteinase (MT1-MMP) expression
JH Hur et al.
JOURNAL OF KOREAN MEDICAL SCIENCE (2000)